| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |